{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:18:30Z","timestamp":1789391910661,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The major targets of HIV infection in humans are CD4<jats:sup>+<\/jats:sup>T cells. CD4<jats:sup>+<\/jats:sup>T cell depletion is a hallmark of AIDS. Previously, the SCID-hu thy\/liv model was used to study the effect of HIV on thymopoeisis<jats:italic>in vivo<\/jats:italic>. However, these mice did not develop high levels of peripheral T cell reconstitution and required invasive surgery for infection and analysis. Here, we describe a novel variant of this model in which thy\/liv implantation results in systemic reconstitution with human T cells in the absence of any other human hematopoietic lineages.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>NOD\/SCID-hu thy\/liv and NSG-hu thy\/liv mice were created by implanting human fetal thymus and liver tissues under the kidney capsule of either NOD\/SCID or NSG mice. In contrast to NOD\/SCID-hu thy\/liv mice that show little or no human cells in peripheral blood or tissues, substantial systemic human reconstitution occurs in NSG-hu thy\/liv. These mice are exclusively reconstituted with human T cells (i.e. T-cell only mice or TOM). Despite substantial levels of human T cells no signs of graft-versus-host disease (GVHD) were noted in these mice over a period of 14 months. TOM are readily infected after parenteral exposure to HIV-1. HIV replication is sustained in peripheral blood at high levels and results in modest reduction of CD4<jats:sup>+<\/jats:sup>T cells. HIV-1 replication in TOM responds to daily administration of combination antiretroviral therapy (ART) resulting in strong suppression of virus replication as determined by undetectable viral load in plasma. Latently HIV infected resting CD4<jats:sup>+<\/jats:sup>T cells can be isolated from suppressed mice that can be induced to express HIV<jats:italic>ex-vivo<\/jats:italic>upon activation demonstrating the establishment of latency<jats:italic>in vivo<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>NSG-hu thy\/liv mice are systemically reconstituted with human T cells. No other human lymphoid lineages are present in these mice (i.e. monocytes\/macrophages, B cells and DC are all absent). These T cell only mice do not develop GVHD, are susceptible to HIV-1 infection and can efficiently maintain virus replication. HIV infected TOM undergoing ART harbor latently infected, resting CD4<jats:sup>+<\/jats:sup>T cells.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1742-4690-10-121","type":"journal-article","created":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T15:19:00Z","timestamp":1382627940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model"],"prefix":"10.1186","volume":"10","author":[{"given":"Jenna B","family":"Honeycutt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancie","family":"Archin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Victor","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,24]]},"reference":[{"key":"3981_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri2017","volume":"7","author":"LD Shultz","year":"2007","unstructured":"Shultz LD, Ishikawa F, Greiner DL: Humanized mice in translational biomedical research. Nat Rev Immunol. 2007, 7: 118-130. 10.1038\/nri2017.","journal-title":"Nat Rev Immunol"},{"key":"3981_CR2","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1084\/jem.172.4.1055","volume":"172","author":"R Namikawa","year":"1990","unstructured":"Namikawa R, Weilbaecher KN, Kaneshima H, Yee EJ, McCune JM: Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med. 1990, 172: 1055-1063. 10.1084\/jem.172.4.1055.","journal-title":"J Exp Med"},{"key":"3981_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1006\/smim.1996.0027","volume":"8","author":"BD Jamieson","year":"1996","unstructured":"Jamieson BD, Aldrovandi GM, Zack JA: The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS. Semin Immunol. 1996, 8: 215-221. 10.1006\/smim.1996.0027.","journal-title":"Semin Immunol"},{"key":"3981_CR4","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1128\/JVI.74.7.3196-3204.2000","volume":"74","author":"D Camerini","year":"2000","unstructured":"Camerini D, Su HP, Gamez-Torre G, Johnson ML, Zack JA, Chen IS: Human immunodeficiency virus type 1 pathogenesis in SCID-hu mice correlates with syncytium-inducing phenotype and viral replication. J Virol. 2000, 74: 3196-3204. 10.1128\/JVI.74.7.3196-3204.2000.","journal-title":"J Virol"},{"key":"3981_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2174\/1570162033485258","volume":"1","author":"EG Meissner","year":"2003","unstructured":"Meissner EG, Duus KM, Loomis R, D\u2019Agostin R, Su L: HIV-1 replication and pathogenesis in the human thymus. Curr HIV Res. 2003, 1: 275-285. 10.2174\/1570162033485258.","journal-title":"Curr HIV Res"},{"key":"3981_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1742-4690-8-65","volume":"8","author":"BK Berges","year":"2011","unstructured":"Berges BK, Rowan MR: The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment. Retrovirology. 2011, 8: 65-10.1186\/1742-4690-8-65.","journal-title":"Retrovirology"},{"key":"3981_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1146\/annurev.iy.09.040191.002151","volume":"9","author":"J McCune","year":"1991","unstructured":"McCune J, Kaneshima H, Krowka J, Namikawa R, Outzen H, Peault B, Rabin L, Shih CC, Yee E, Lieberman M: The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu Rev Immunol. 1991, 9: 399-429. 10.1146\/annurev.iy.09.040191.002151.","journal-title":"Annu Rev Immunol"},{"key":"3981_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1742-4690-6-76","volume":"6","author":"R Van Duyne","year":"2009","unstructured":"Van Duyne R, Pedati C, Guendel I, Carpio L, Kehn-Hall K, Saifuddin M, Kashanchi F: The utilization of humanized mouse models for the study of human retroviral infections. Retrovirology. 2009, 6: 76-10.1186\/1742-4690-6-76.","journal-title":"Retrovirology"},{"key":"3981_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nri3311","volume":"12","author":"LD Shultz","year":"2012","unstructured":"Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL: Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol. 2012, 12: 786-798. 10.1038\/nri3311.","journal-title":"Nat Rev Immunol"},{"key":"3981_CR10","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1182\/blood.V99.8.2851","volume":"99","author":"Y Okamoto","year":"2002","unstructured":"Okamoto Y, Douek DC, McFarland RD, Koup RA: Effects of exogenous interleukin-7 on human thymus function. Blood. 2002, 99: 2851-2858. 10.1182\/blood.V99.8.2851.","journal-title":"Blood"},{"key":"3981_CR11","doi-asserted-by":"publisher","first-page":"574967","DOI":"10.1155\/2012\/574967","volume":"2012","author":"W Abbas","year":"2012","unstructured":"Abbas W, Herbein G: Molecular understanding of HIV-1 latency. Adv Virol. 2012, 2012: 574967-","journal-title":"Adv Virol"},{"key":"3981_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1128\/JVI.05590-11","volume":"86","author":"SK Choudhary","year":"2012","unstructured":"Choudhary SK, Archin NM, Cheema M, Dahl NP, Garcia JV, Margolis DM: Latent HIV-1 infection of resting CD4 T cells in the humanized Rag2\/ gammac\/ mouse. J Virol. 2012, 86: 114-120. 10.1128\/JVI.05590-11.","journal-title":"J Virol"},{"key":"3981_CR13","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1128\/JVI.06120-11","volume":"86","author":"PW Denton","year":"2012","unstructured":"Denton PW, Olesen R, Choudhary SK, Archin NM, Wahl A, Swanson MD, Chateau M, Nochi T, Krisko JF, Spagnuolo RA, et al: Generation of HIV latency in humanized BLT mice. J Virol. 2012, 86: 630-634. 10.1128\/JVI.06120-11.","journal-title":"J Virol"},{"key":"3981_CR14","doi-asserted-by":"publisher","first-page":"16934","DOI":"10.1073\/pnas.1002894107","volume":"107","author":"PU Cameron","year":"2010","unstructured":"Cameron PU, Saleh S, Sallmann G, Solomon A, Wightman F, Evans VA, Boucher G, Haddad EK, Sekaly RP, Harman AN, et al: Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton. Proc Natl Acad Sci USA. 2010, 107: 16934-16939. 10.1073\/pnas.1002894107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3981_CR15","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1182\/blood-2007-06-097907","volume":"110","author":"S Saleh","year":"2007","unstructured":"Saleh S, Solomon A, Wightman F, Xhilaga M, Cameron PU, Lewin SR: CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency. Blood. 2007, 110: 4161-4164. 10.1182\/blood-2007-06-097907.","journal-title":"Blood"},{"key":"3981_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","volume":"96","author":"JR Schoenborn","year":"2007","unstructured":"Schoenborn JR, Wilson CB: Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007, 96: 41-101.","journal-title":"Adv Immunol"},{"key":"3981_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nri1052","volume":"3","author":"KS Schluns","year":"2003","unstructured":"Schluns KS, Lefrancois L: Cytokine control of memory T-cell development and survival. Nat Rev Immunol. 2003, 3: 269-279. 10.1038\/nri1052.","journal-title":"Nat Rev Immunol"},{"key":"3981_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1742-4690-8-80","volume":"8","author":"S Saleh","year":"2011","unstructured":"Saleh S, Wightman F, Ramanayake S, Alexander M, Kumar N, Khoury G, Pereira C, Purcell D, Cameron PU, Lewin SR: Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells. Retrovirology. 2011, 8: 80-10.1186\/1742-4690-8-80.","journal-title":"Retrovirology"},{"key":"3981_CR19","doi-asserted-by":"publisher","first-page":"e44664","DOI":"10.1371\/journal.pone.0044664","volume":"7","author":"MB Greenblatt","year":"2012","unstructured":"Greenblatt MB, Vrbanac V, Tivey T, Tsang K, Tager AM, Aliprantis AO: Graft versus host disease in the bone marrow, liver and thymus humanized mouse model. PLoS One. 2012, 7: e44664-10.1371\/journal.pone.0044664.","journal-title":"PLoS One"},{"key":"3981_CR20","volume-title":"Clin Exp Immunol","author":"L Covassin","year":"2013","unstructured":"Covassin L, Jangalwe S, Jouvet N, Laning J, Burzenski L, Shultz LD, Brehm MA: Human immune system development and survival of NOD-scid IL2rgamma (NSG) mice engrafted with human thymus and autologous hematopoietic stem cells. Clin Exp Immunol. 2013, doi:10.1111\/cei.12180"},{"key":"3981_CR21","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.4049\/jimmunol.146.11.3751","volume":"146","author":"JF Krowka","year":"1991","unstructured":"Krowka JF, Sarin S, Namikawa R, McCune JM, Kaneshima H: Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent. J Immunol. 1991, 146: 3751-3756.","journal-title":"J Immunol"},{"key":"3981_CR22","volume-title":"Cellular and Molecular Immunology","author":"A Abbas","year":"2010","unstructured":"Abbas A, Lichtman A, Pillai S: Cellular and Molecular Immunology. 2010, Philadelphia, PA: Saunders Elsevier, 6","edition":"6"},{"key":"3981_CR23","doi-asserted-by":"publisher","first-page":"7305","DOI":"10.1128\/JVI.02207-08","volume":"83","author":"DM Brainard","year":"2009","unstructured":"Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, Hart WK, Shin HS, Brooks SF, Knight HL, Eichbaum Q, et al: Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol. 2009, 83: 7305-7321. 10.1128\/JVI.02207-08.","journal-title":"J Virol"},{"key":"3981_CR24","doi-asserted-by":"publisher","first-page":"7582","DOI":"10.1128\/JVI.00537-11","volume":"85","author":"PW Denton","year":"2011","unstructured":"Denton PW, Othieno F, Martinez-Torres F, Zou W, Krisko JF, Fleming E, Zein S, Powell DA, Wahl A, Kwak YT, et al: One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates. J Virol. 2011, 85: 7582-7593. 10.1128\/JVI.00537-11.","journal-title":"J Virol"},{"key":"3981_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1742-4690-10-67","volume":"10","author":"C Van Lint","year":"2013","unstructured":"Van Lint C, Bouchat S, Marcello A: HIV-1 transcription and latency: an update. Retrovirology. 2013, 10: 67-10.1186\/1742-4690-10-67.","journal-title":"Retrovirology"},{"key":"3981_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1086\/505147","volume":"194","author":"RP Walensky","year":"2006","unstructured":"Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA: The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006, 194: 11-19. 10.1086\/505147.","journal-title":"J Infect Dis"},{"key":"3981_CR27","first-page":"134","volume":"1","author":"NM Archin","year":"2006","unstructured":"Archin NM, Margolis DM: Attacking latent HIV provirus: from mechanism to therapeutic strategies. Curr Opin HIV AIDS. 2006, 1: 134-140.","journal-title":"Curr Opin HIV AIDS"},{"key":"3981_CR28","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1097\/QAD.0b013e3282fd6df4","volume":"22","author":"NM Archin","year":"2008","unstructured":"Archin NM, Eron JJ, Palmer S, Hartmann-Duff A, Martinson JA, Wiegand A, Bandarenko N, Schmitz JL, Bosch RJ, Landay AL, et al: Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells. AIDS. 2008, 22: 1131-1135. 10.1097\/QAD.0b013e3282fd6df4.","journal-title":"AIDS"},{"key":"3981_CR29","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nm880","volume":"9","author":"JD Siliciano","year":"2003","unstructured":"Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF: Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med. 2003, 9: 727-728. 10.1038\/nm880.","journal-title":"Nat Med"},{"key":"3981_CR30","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/8394","volume":"5","author":"D Finzi","year":"1999","unstructured":"Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, et al: Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. 1999, 5: 512-517. 10.1038\/8394.","journal-title":"Nat Med"},{"key":"3981_CR31","first-page":"13618","volume":"142","author":"M Nischang","year":"2012","unstructured":"Nischang M, Gers-Huber G, Audige A, Akkina R, Speck RF: Modeling HIV infection and therapies in humanized mice. Swiss Med Wkly. 2012, 142: 13618-","journal-title":"Swiss Med Wkly"},{"key":"3981_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1357-4310(97)01046-0","volume":"3","author":"ML Bonyhadi","year":"1997","unstructured":"Bonyhadi ML, Kaneshima H: The SCID-hu mouse: an in vivo model for HIV-1 infection in humans. Mol Med Today. 1997, 3: 246-253. 10.1016\/S1357-4310(97)01046-0.","journal-title":"Mol Med Today"},{"key":"3981_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1084\/jem.179.2.513","volume":"179","author":"TR Kollmann","year":"1994","unstructured":"Kollmann TR, Pettoello-Mantovani M, Zhuang X, Kim A, Hachamovitch M, Smarnworawong P, Rubinstein A, Goldstein H: Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. J Exp Med. 1994, 179: 513-522. 10.1084\/jem.179.2.513.","journal-title":"J Exp Med"},{"key":"3981_CR34","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","volume":"174","author":"LD Shultz","year":"2005","unstructured":"Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, et al: Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol. 2005, 174: 6477-6489.","journal-title":"J Immunol"},{"key":"3981_CR35","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.celrep.2013.05.037","volume":"3","author":"T Nochi","year":"2013","unstructured":"Nochi T, Denton PW, Wahl A, Garcia JV: Cryptopatches are essential for the development of human GALT. Cell Rep. 2013, 3: 1874-1884. 10.1016\/j.celrep.2013.05.037.","journal-title":"Cell Rep"},{"key":"3981_CR36","doi-asserted-by":"publisher","first-page":"125ra130","DOI":"10.1126\/scitranslmed.3003481","volume":"4","author":"H Kalscheuer","year":"2012","unstructured":"Kalscheuer H, Danzl N, Onoe T, Faust T, Winchester R, Goland R, Greenberg E, Spitzer TR, Savage DG, Tahara H, et al: A model for personalized in vivo analysis of human immune responsiveness. Sci Transl Med. 2012, 4: 125ra130-","journal-title":"Sci Transl Med"},{"key":"3981_CR37","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1371\/journal.pmed.0050016","volume":"5","author":"PW Denton","year":"2008","unstructured":"Denton PW, Estes JD, Sun Z, Othieno FA, Wei BL, Wege AK, Powell DA, Payne D, Haase AT, Garcia JV: Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med. 2008, 5: e16-10.1371\/journal.pmed.0050016.","journal-title":"PLoS Med"},{"key":"3981_CR38","doi-asserted-by":"publisher","first-page":"e8829","DOI":"10.1371\/journal.pone.0008829","volume":"5","author":"PW Denton","year":"2010","unstructured":"Denton PW, Krisko JF, Powell DA, Mathias M, Kwak YT, Martinez-Torres F, Zou W, Payne DA, Estes JD, Garcia JV: Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS One. 2010, 5: e8829-10.1371\/journal.pone.0008829.","journal-title":"PLoS One"},{"key":"3981_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jri.2010.11.005","volume":"88","author":"R Olesen","year":"2011","unstructured":"Olesen R, Wahl A, Denton PW, Garcia JV: Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection. J Reprod Immunol. 2011, 88: 195-203. 10.1016\/j.jri.2010.11.005.","journal-title":"J Reprod Immunol"},{"key":"3981_CR40","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/mi.2012.31","volume":"5","author":"PW Denton","year":"2012","unstructured":"Denton PW, Nochi T, Lim A, Krisko JF, Martinez-Torres F, Choudhary SK, Wahl A, Olesen R, Zou W, Di Santo JP, et al: IL-2 receptor gamma-chain molecule is critical for intestinal T-cell reconstitution in humanized mice. Mucosal Immunol. 2012, 5: 555-566. 10.1038\/mi.2012.31.","journal-title":"Mucosal Immunol"},{"key":"3981_CR41","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1128\/JVI.79.9.5705-5712.2005","volume":"79","author":"BL Wei","year":"2005","unstructured":"Wei BL, Denton PW, O\u2019Neill E, Luo T, Foster JL, Garcia JV: Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection. J Virol. 2005, 79: 5705-5712. 10.1128\/JVI.79.9.5705-5712.2005.","journal-title":"J Virol"},{"key":"3981_CR42","doi-asserted-by":"publisher","first-page":"e1002732","DOI":"10.1371\/journal.ppat.1002732","volume":"8","author":"A Wahl","year":"2012","unstructured":"Wahl A, Swanson MD, Nochi T, Olesen R, Denton PW, Chateau M, Garcia JV: Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice. PLoS Pathog. 2012, 8: e1002732-10.1371\/journal.ppat.1002732.","journal-title":"PLoS Pathog"},{"key":"3981_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/aid.2008.0191","volume":"25","author":"NM Archin","year":"2009","unstructured":"Archin NM, Espeseth A, Parker D, Cheema M, Hazuda D, Margolis DM: Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res Hum Retroviruses. 2009, 25: 207-212. 10.1089\/aid.2008.0191.","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-10-121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T15:46:47Z","timestamp":1688572007000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-10-121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,24]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3981"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-10-121","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,24]]},"assertion":[{"value":"14 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"121"}}